Search results
Results From The WOW.Com Content Network
Immunosuppression is a reduction of the activation or efficacy of the immune system. Some portions of the immune system itself have immunosuppressive effects on other parts of the immune system, and immunosuppression may occur as an adverse reaction to treatment of other conditions.
The immunosuppressive drugs also interact with other medicines and affect their metabolism and action. Actual or suspected immunosuppressive agents can be evaluated in terms of their effects on lymphocyte subpopulations in tissues using immunohistochemistry. [14]
Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system.Immunotherapy is designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
Under the HITECH Act, the United States Department of Health and Human Services (U.S. HHS) resolved to spend $25.9 billion to promote and expand the adoption of health information technology. [1] The Washington Post reported the inclusion of "as much as $36.5 billion in spending to create a nationwide network of electronic health records ."
It was approved for medical use in the United States in 1995 following the discovery of its immunosuppressive properties in the 1990s. [13] [14] It is available as a generic medication. [16] In 2022, it was the 227th most commonly prescribed medication in the United States, with more than 1 million prescriptions. [17] [18]
A pair of federal government provisions designed to reduce excessive Social Security payouts are once again being targeted for elimination by U.S. lawmakers. At issue are the Windfall Elimination...
The explanation for this is that while "biologic" or "biopharmaceutical" refers to the chemical composition of medications which might be used to treat a range of medical conditions, when the term "biologic" became popular, many biologic medications available provided immunosuppression.
Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome, COVID‑19, and systemic sclerosis-associated interstitial lung disease (SSc-ILD).